AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Borsen-Zeitung)
Schering, the German pharmaceuticals group, is planning to buy back nearly 1 per cent of its own shares during the next five weeks in order to give a boost to its own share price. The Berlin-based group recorded an 11 per cent ebit increase to 741m euros last year. Turnover rose by 4 per cent in 2002, while sales were up 10 per cent.
Management has attributed the underproportionate turnover increase to the weak US dollar ...